HighTower Trust’s Chemours CC Stock Holding History

HighTower Trust’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,219	Closed	-$1.67K	–	248
2022 Q2	$1.67K	Buy	+13,219	New	+$486K	0.18%	77

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HighTower Trust's CC Position: Q3 2022 in Review

HighTower Trust sold out of Chemours (CC) in Q3 2022, closing a stake of 13,219 shares — an estimated $1.67K sold.

HighTower Trust first reported a position in CC in Q2 2022 and held it in 1 quarter. The position peaked at $1.67K in Q2 2022. 487 funds tracked by Wall St. Rank hold CC as of Q3 2022.

HighTower Trust reported no remaining Chemours position as of Q3 2022 after selling out during the quarter.
HighTower Trust sold 13,219 Chemours shares in Q3 2022, an estimated $1.67K.
HighTower Trust first reported a position in Chemours in Q2 2022 and held it in 1 quarter.
HighTower Trust's Chemours position peaked at $1.67K in Q2 2022.
487 funds tracked by Wall St. Rank held Chemours as of Q3 2022.

Based on HighTower Trust's 13F filing for Q3 2022, filed 7 Oct 2022.